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Impaired myocardial lipid metabolism in phosphate depletion. This
study examines the effects of phosphate depletion on myocardial
carbohydrate, lipid, and phospholipid metabolism. Rats were studied
after 4 (short-term) and 8 to 12 weeks (long-term) of selective dietary
phosphate restriction. Myocardial biopsy samples were examined for
glucose-6-phosphate and glycogen to evaluate carbohydrate pathways,
and for glycerol phosphate and mitochondrial fatty acid oxidation and
phospholipid contents to evaluate lipid and phospholipid turnover. The
fall in cellular inorganic phosphorus was associated with a fall in myo-
cardial glycogen, glucose-6-phosphate, glycerol phosphate, and cyti-
dine triphosphate, as well as the contents of phosphatidylcholine,
phosphatidylethanolamine, and total phospholipid phosphorus. These
observations demonstrate impaired phospholipid metabolism, prob-
ably at the biosynthetic level. The oxidation of long-chain and short-
chain fatty acids is also impaired in phosphate depletion, further
demonstrating impaired lipid metabolism. The abnormal phospholipid
metabolism may be compatible with the changes in cellular membrane
described in phosphate depletion.
Alteration du métabolisme lipidique myocardique lors d'une depletion
phosphatée. Cette étude examine les effets d'une dépldtion phosphatée
sur le métabolisme myocardique des hydrates de carbone, des lipides
et des phospholipides. Des rats ont été étudiés après une reduction
phosphatée alimentaire selective de 4 (court terme) et de 8 a 12 (long
terme) semaines. Des biopsies myocardiques ont été étudiées pour leur
contenu en glucose-6-phosphate et en glycogene afin d'évaluer les vo-
ies métaboliques des hydrates de carbone et pour leur importance en
glycerol-phosphate, en oxydation mitochondirale des acides gras et en
phospholipides pour évaluer Ic renouvellement lipidique et phospho-
lipidique. La chute du phosphore inorganique cellulaire était associée
a une baisse du glycogene, du glucose, du glucose-6-phosphate, du
glycerol-phosphate et de la cytidine-triphosphate myocardiques, ainsi
qu'à une baisse des contenus en phosphatidylcholine, phosphatidyl-
ethanolamine et en phosphore total phospholipidique. Ces observa-
tions démontrent l'altération du métabolisme phospholipidique proba-
blement au niveau de Ia biosynthese. L'oxydation des acides gras a
longues et a courtes chaines est egalement altérëe lors de la déplétion
phosphatée, ce qui démontre encore l'anomalie du métabolisme lipid-
ique. Ce métabolisme phospholipidique anormal pourrait être compat-
ible avec les modifications de Ia membrane cellulaire décrits au cours
de Ia depletion phosphatee.
Phosphate depletion is associated with impaired myocardial
contractility and congestive cardiomyopathy [11. The cellular
events of this cardiomyopathy are associated with impaired
mitochondrial energy production, energy transport and utiliza-
tion [2], and these derangements are considered to be the con-
sequences of depletion of intracellular phosphorus stores [21.
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Because inorganic phosphorus and ATP are major sub-
strates for carbohydrate, lipid, and phospholipid metabolism, it
is possible that impairment in one or all of these processes may
contribute to the cardiomyopathy of phosphate depletion. This
study was therefore designed to examine the effects of short-
term and long-term phosphate depletion on myocardial carbo-
hydrate, lipid, and phospholipid metabolism.
Methods
Sprague-Dawley rats (body wt, 150 to 200 g) were studied af-
ter short-term (4 weeks) and long-term (8 to 12 weeks) selec-
tive dietary phosphorus restriction. The animals were fed rat
chow containing 0.025% phosphorus. As control, another
group of weight- and age-matched rats were pair-fed with diets
containing 0.35% phosphorus. On the day of the experiments,
rats were anesthetized with an intraperitoneal injection of pen-
tobarbital (5 mg/kg) intubated, and respirated to maintain a Po2
of 80 to 85 mm Hg and a Pco2 of 38 to 40 mm Hg. The chest
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was opened, and a myocardial biopsy was obtained by freeze-
clamp techniques [2]. The biopsy samples were obtained from
the anterior left ventricular wall, by the same investigator at all
times. The samples were then processed for the evaluation of
acid-extractable phospholipid precursors and glycerol, as well
as for butanol-extractable tissue phospholipids. Blood samples
were collected for the measurement of serum inorganic phos-
phorus.
Acid extraction. The myocardial samples were pulverized
with a mortar and pestle under liquid nitrogen as described by
Lowry and Passonneau [31. After complete pulverization, the
samples were extracted with 3 M perchloric acid at 10° C to
allow complete penetration and fixation of the powder by the
acid [31. The solution was then centrifuged, and the super-
natant was removed and neutralized with a small amount of
saturated solution of potassium carbonate. The mixture was
kept at 2° C for 15 minutes, centrifuged, and the potassium per-
chlorate precipitate removed. The extract was processed for
inorganic phosphorus, acid-extractable water-soluble phospho-
lipid precursors, and glucose-6-phosphate using a Bessman au-
tomatic phosphate analyzer (which is, in principle, high-pres-
sure liquid chromatography on an anion-exchange resin col-
umn for separation of phosphorylated intermediates). Final
ashing and colorimetric determinations were made on comple-
tion of the separation [2—5].
The phospholipid precursors separated were phosphocho-
line (PC), phosphoethanolamine (PE), and cytidine triphos-
phate (CTP). All peaks were compared with authentic stan-
dards and co-chromatography was performed for final identi-
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fication of peaks. In all extracts, glycerol phosphate and
glycogen were measured by enzymatic methods, based on a
modification of the method described by Bergmyer et al [61.
Phospholipid extraction and analysis. Biopsy samples were
extracted for phospholipids by a modification of the method de-
scribed by Bligh and Dyer [7]. Phospholipids were analyzed by
thin-layer chromatography (TLC) and high-pressure liquid
chromatography (HPLC). Phosphorus was analyzed by the
Bessman ashomatic phosphorus analysis.
(a) Thin-layer chromatography. The sample was plated on
silica gel plates activated with magnesium acetate (Supelco
Inc., Bellefonte, PA) and developed with a two-solvent sys-
tem. The first system was chloroform, methanol, and ammonia
(65:25:5), and the second was chloroform, acetone, methanol,
acetic acid, and water (3:4:1:1:0,5).
The phospholipids were spotted with iodine vapor spray, and
each spot was identified with co-chromatography of original
standards obtained from Sigma Biochemicals, St. Louis, MO.
The spots were then scraped, and inorganic phosphorus was
measured by the Bartlett method [8].
(b) High-pressure liquid chromatography. High-pressure liq-
uid chromatography was performed with a Water Associates
liquid chromatographic system comprising a U.K. injector, a
model 6000A pump, a Whatman PXS 10/25 SCX column (25 cm
x 4.6 mm I.D.) packed with 10 tm of silica with covalently
bound benzene sulfonate, and a Whatman guard column, 7 cm
x 2.1 mm ID., packed with 10 to 40 m of SCX pellicolor me-
dia, placed directly in front of the column. Acetonitrile, metha-
nol, and water (all HPLC grade) were used as solvents. After
separation of the peaks, phosphorus analysis was done with the
automatic Bessman phosphorus analysis as described previ-
ously by Kaitaranta and Bessman [91. A representative run is
shown in Figure 1.
Fatty acid oxidation. Heart mitochondria were isolated from
8 weeks' phosphate depleted and normal rats. Rats were de-
capitated, hearts were removed immediately and washed in
normal saline, and mitochondria were isolated by the modifi-
cation of Yang, Geiger, and Bessman [101.
Respiratory control rate, ADP:O ratios, and oxygen con-
sumption (with a-ketoglutarate as a substrate) were calculated
in every experiment to eliminate malfunctioning mitochondria
secondary to isolation techniques [111. Oxygen consumption
was determined polarographically by the use of the Clark elec-
trode [11]. Both long-chain and short-chain fatty acid oxida-
tion was evaluated.
(a) Long-chain fatty acids. Activated fatty acids palmitoyl
co-enzyme-A was purchased from Sigma Biochemicals. The
oxygraph media contained 0.23 M mannitol, 70 m sucrose, 1
mM malate, 20 m'vi tris chloride, 0.020 EDTA, and, as buffer 5
m potassium phosphate. The final pH was 7.2 and tempera-
ture, 28° C. A 100-p1 sample of mitochondria were added to the
incubation medium in the oxygraph chamber. At this point, 50
p1 of 2 mrvi carnitine and 30 p1 of 0.1 mrs's palmitoyl co-en-
zyme-A were added to the incubation chamber, and oxygen
consumption was recorded. Results were calculated according
to Chance and Williams [111 and expressed as nanomoles of
oxygen per milligram of protein per minute.
(b) Short-chain fatty acids. Beta-hydroxy butyric acid was
obtained from Sigma Biochemicals. The same medium was
used for short-chain fatty acids. A sample of 100 p1 of mito-
Fig. 1. Separation of phospholipid by high-pressure liquid chromatog-
raphy and automatic phosphate analysis. Abbreviations are defined as
follows: Pi, inorganic phosphorus standards; P1, phosphatidylinositol;
PA, phosphatidic acid; PE, phosphatidylethanolamine; PC, phospha-
tidylcholine; LPE, lysophosphatidylethanolamine; LPC, lysophospha-
tidyicholine; SM, sphingomyeline.
chondria were added to the incubation oxygraph vessel, and 50
p1 of 0.4 m beta hydroxy butyric acid added. This acid was
used to examine short-chain fatty acid oxidation.
Results
The concentration of serum phosphorus was significantly re-
duced after 4 weeks (8.5 0.1 vs. 5.0 0.4 mg/dl, P < 0.01)
and 8 to 12 weeks (8.4 0.5 vs. 3.3 0.2 mg/dl, P < 0.01).
The changes in myocardial inorganic phosphorus, glycerol
phosphate, glucose-6-phosphate, and glycogen are given in Ta-
ble 1. The concentrations of inorganic phosphorus and glyc-
erol phosphate were significantly reduced (P < 0.01) both after
4 and 8 to 12 weeks of phosphate depletion. In contrast, the
concentrations of cytidine triphosphate, glucose-6-phosphate,
and glycogen were reduced (P 0.01) only after 8 to 12 weeks
of phosphate depletion. The changes in glucose-6-phosphate
glycogen and glycerol phosphate were significantly correlated
with the changes in intercellular inorganic phosphorus (Figs. 2
to 4).
Phospholipids. The changes in major cellular phospholipids
are shown in Table 2. After 8 to 12 weeks of phosphate deple-
tion, there was a significant fall in the content of phosphati-
dylcholine from 57.2 1.6 to 29.3 4.1% phospholipid phos-
phorus (P < 0.01), and phosphatidylethanolamine from 39.2
3.0 to 24.0 4.0% phospholipid phosphorus (P < 0.05). The
ratio of phosphatidylcholine to phosphatidylethanolamine was
significantly altered with phosphate depletion from 1.58 0.05
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Table 1. Effects of phosphate depletion on myocardial cellular phospholipid metabolism and carbohydrate pathwaysa
Study group
Serum
phosphate
mg/dl
Cellular inorganic
phosphate
moles/g of protein
Glycerol phosphate
moles/g of protein
Glucose-6-
phosphate
moles/g ofprotein
Glycogen
gImg of protein
-
Cytidine
triphosphate
nmoles/g of protein
Short-term (4 weeks)
normal diet 8.5 0.1 28.2 3.5 325.0 36.0 5.0 0.9 62.0 9.0 330 40
low phosphate diet 5.0 0.4* 13.6 1.4* 270.0 46.0** 5.2 0.5 — 340 23
Long-term (8 to 12
weeks)
normal diet 8.4 0.5 28.8 2.2 405.0 51.0 3.8 0.6 62.2 3.1 403 41
low phosphate diet 3.3 0.2* 12.0 1.8* 119.0 12,0* 1.35 0.2* 27.0 3.0* 288 31*
a Values are the means SEM of 8 to 12 rats. Statistical significance is denoted by asterisks: * < 0.01, < 0.05.
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Cellular inorganic phosphorus, pmoles/g of protein
Fig. 2. Correlation between myocardial inorganic phosphorus and glu-
cose-6-phosphate contents. Each data point represents one rat. Both
normal and phosphate-depleted rats are depicted.
S
Cellular inorganic phosphorus, moIes/g of protein
Fig. 3. Correlation between myocardial inorganic phosphorus and
glycerol phosphale contents. Each data point represents one rat. Both
normal and phosphate-depleted rats are depicted.
Cellular inorganic phosphorus, ,.moIes/g of protein
Fig. 4. Correlation between myocardial inorganic phosphorus and gly-
cogen contents. Each data point represents one rat. Both normal and
phosphate-depleted rats are depicted.
ids (89.7 11.32 vs. 37.20 4.1 nmoles of oxygen per milli-
gram of protein per minute; P < 0.01). Respiratory control rate
and ADP:O ratios were not different, indicating intact coupled
mitochondria.
To further evaluate whether the impaired fatty acid oxida-
tion was the result of reduced mitochondrial acylcarnitine
transferase activity, we examined short-chain fatty acid oxi-
dation, There was a marked reduction in the ability of mito-
chondria from phosphate-depleted rats to oxidize short-chain
fatty acids (38.35 2.11 vs. 9.3 3.12 nmoles of oxygen per
milligram of protein per minute; P < 0.01, Table 3). Oxygen
consumption at the resting state (state IV respiration) was also
impaired (Table 3).
Discussion
Previous studies from our laboratory have shown that phos-
phate depletion is associated with impaired myocardial energy
production, transfer, and utilization 21. The results of the pre-
sent study extend these observations and may provide an in-
sight into the mechanisms that lead to decreased energy pro-
duction. The data demonstrate that phosphate depletion im-
pairs myocardial carbohydrate and lipid metabolism.
The reduction in the myocardial concentration of glucose-6-
phosphate and glycogen is compatible with impaired glycolytic
activity and decreased glycogen synthesis. The finding that the
changes in glucose-6-phosphate levels were correlated with the
reduced myocardial concentration of inorganic phosphorus
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to 1.25 0.09 (P < 0.01). There was also a significant fall in
total phospholipid phosphorus from 8700 680 to 5900 570
mmoles/g of protein (P < 0.01).
Mitochondrial oxidation of long-chain fatty acids was mark-
edly reduced in 8 to 12 weeks of phosphate depletion (Table 3).
Mitochondria from phosphate-depleted rats demonstrated a
marked reduction in the ability to oxidize long-chain fatty ac-
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Table 2. Effects of phosphate depletion on phospholipid composition of myocardial ce1ls'
Study group
Phosphatidyl- Phosphatidyl- Phosphatidyl-
ethanolamine choline inositol
(PE) (PC) (P1) PC:PE
% of phospholipid phosphorus
Normal diet
Low phosphate diet
39.2 3.0 57.2 1.6 4.9 0.8
24.0 4.0** 29.3 4.1* 5.1 0.6
1.60
1.30
0.05
0.09*
a Values are the means SEM of 8 rats. Statistical significance is denoted by asterisks: * < < 0.05.
Table 3. Effects of phosphate depletion on the oxidation of short- and long-chain fatty acids'
Short-chain fatty acids Long-chain fatty acids
Study group RC ADP:O S1V02 S4V02 RC ADP:O S3V02 S4V02
Normal diet 6.6 0.8 3.1 0.2 38.3 2.1 6.14 0.80 5.3 0.6 3.1 0.1 89.7 11.3 15.0 2.1
Low phosphate diet 5.6 1.2 3.3 0.5 9.3 2.1* 2.13 0.43* 6.6 0.7 3.2 0.2 37.2 4.1* 7.2 0.8*
a Values are the means SEM of 8 rats. Statistical significance is denoted by an asterisk: *< 0.01.
Abbreviations are defined as follows: RC, respiratory control; S3V02, oxygen consumption with ADP stimulation, expressed as nanomoles of
oxygen per milligram of protein per minute; S4V02, oxygen consumption with no ADP stimulation and maximal ATP saturation, expressed as
nanomoles of oxygen per milligram of protein per minute.
suggests a possible impairment in the phosphorylation of glu-
cose to glucose-6-phosphate. Indeed, decreased glucose up-
take, as well as insulin resistance, has been reported in
hypophosphatemic patients [12] and rats [131. Increased glu-
cose-6-phosphate utilization could also be present and contrib-
ute to its reduced cellular content. Our data do not support or
refute this possibility. The metabolic pathway of glucose-6-
phosphate, however, is facilitated by phosphofructokinase.
This enzyme is sensitive to the cellular concentration of in-
organic phosphorus and is inhibited when the latter is low. It
is reasonable to suggest that in phosphate depletion, the activ-
ity of this enzyme is reduced, and, therefore, that increased uti-
lization of glucose-6-phosphate does not occur.
The reduced cellular levels of glycogen are compatible with
impaired glucose phosphorylation and glycogen synthesis, but
the possibility of increased glycogen breakdown cannot be
ruled out. Indeed, Horl et al [141 have reported both de-
creased glycogen synthesis and increased glycogen breakdown
in the myocardium of phosphate-depleted rabbits.
The finding of reduced oxidation of both long- and short-
chain fatty acids suggests the presence of impairments at vari-
ous steps of the mitochondrial processes reponsible for the oxi-
dation of fatty acids. The transport and oxidation of long-chain
fatty acids require intact activity of acylcarnitine transferase of
the outer and inner mitochondrial membrane, adequate carni-
tine content, and sufficient acyl-CoA [15, 16]. Therefore, a de-
fect in any of these steps could account for the reduced oxi-
dation of long-chain fatty acids. In contrast, short-chain fatty
acids enter mitochondria freely and independent of the activity
of acylcarnitine transferase or carnitine [15]. Therefore, im-
paired oxidation of short-chain fatty acids should indicate an
intramitochondrial abnormality such as depletion of acyl-Coa.
The observation that Co-A synthesis requires ATP for its syn-
thesis, and the levels of the latter are reduced in phosphate de-
pletion [2], is further compatible with the notion of an intrami-
tochondrial impairment in fatty acid oxidation. Such a derange-
ment could also be responsible for the impaired oxidation of
the long-chain fatty acids.
The observation of a marked reduction in oxygen consump-
tion at stage IV respiration deserves a comment. Uncoupled
mitochondria owing to mechanical or technical causes or sec-
ondary to impaired integrity of mitochondrial membrane are as-
sociated with increased oxygen consumption at stage IV res-
piration. Our finding of reduced oxygen consumption at stage
IV is compatible with either a reduction in the oxygen uptake
by the respiratory chain or a reduction in the number of units
in the respiratory chain.
Several lines of evidence suggest an abnormality of cell
membrane integrity in phosphate depletion. Insulin resistance
and impaired cellular glucose uptake have been described in
phosphate-depleted dogs [17], rats [13], and patients [121.
Fuller et a! [18] reported reduced resting membrane potential
in skeletal muscle of phosphate-depleted dogs, and Campese et
al [19] recently reported an end-organ resistance to pressor
agonists. The derangement in cell membrane integrity may be
due to abnormalities in phospholipid biosynthesis. Indeed, the
findings of reduced phosphatidylcholine (PC), phosphatidyl-
ethanolamine (PD), and total phospholipid phosphorus in the
myocardium of phosphate-depleted rats demonstrate the im-
paired biochemical integrity of cell membrane. Furthermore,
the observation of altered ratios of PC to PE is compatible with
altered membrane phospholipid abnormality and possibly func-
tion. It is of interest to note that the sum of the measured
phospholipids in the normal rats was 101.3% versus 58.4% in
phosphate-depleted rats. This difference can be explained by
either (1) a diversion of the normal biosynthetic pathways of
phospholipids and, in turn, an increased production of
phosphatidylserine, sphingomyelin, or diphosphatidylglycerol,
or (2) an increased breakdown of the major phospholipids via
activation of cellular phospholipases, and the production of
lysocompounds. Because we have not measured all fractions of
cellular phospholipids, our findings cannot rule out an in-
creased synthesis of sphingomyelin or phosphatidylserine as a
result of some diversion of the biosynthetic pathway which
may occur in phosphate depletion. The findings of no changes
in the concentration of phosphatidylinositol, phosphatidic acid,
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Fig. 5. Biosynthesis of phospholipids. There
are two major pathways: One originates from
glycerol phosphate and derives from
glycolysis for the production of phosphatidic
acid (1). The other one originates from
choline, and the phosphorylation of choline
via choline kinase and ATP (2), followed by
activation with CTP (3), to form CDP-choline.
The final step is the production of
phosphatidyl choline and
phosphatidylethanolamine (4).
lysophosphotidyicholine, and lysophosphatidylethanolamine
make it unlikely that the changes in total phospholipid phos-
phoriis are the result of activation of cellular phospholipases
and breakdown of major phospholipid compounds.
Our data here do not allow us to delineate what part of the
cellular membrane is affected. Both plasma membrane and
subcellular membrane parts can be affected. The observation
of a reduced resting respiratory rate of mitochondria from
phosphate-depleted rats is against an impairment of mitochon-
drial membrane, because the latter will be expected to be as-
sociated with increased resting mitochondrial oxygen con-
sumption. Thus, it seems that the plasma membrane or sar-
coplasmic reticulum might be affected. Indeed, Kreusser et al
[201 have reported a reduction in phospholipid content in the
sarcoplasmic reticulum from phosphate-depleted rabbits. Elec-
tron microscopic studies of isolated membrane studies will be
needed to localize this defect.
The reduced cellular levels of cytidine triphosphate (CTP)
and glycerol phosphate in phosphate depletion suggest a de-
fect in the synthesis of phospholipids rather than an increased
breakdown, because CTP is a major coenzyme in the biosyn-
thesis of phospholipids [211! (Fig. 5). Since CTP is derived from
ATP and CPD, it is plausible to suggest that the reduced myo-
cardial levels of ATP described in phosphate depletion [2]
could be associated with a reduction in CTP levels and, in turn,
could impair the biosynthesis of phospholipids.
These data are compatible with impaired phospholipid bio-
synthesis and with the clinical and experimental findings of im-
paired cellular membrane function described in phosphate
depletion.
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